Strategies & Market Trends : Low Price/Cash Ratio Value Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stock leader who wrote (1716)10/2/2017 8:09:04 PM
From: Elroy  Read Replies (2) of 1799
Damn, someone has decided that ITEK's new drug pipeline is a good one. $1.94 now......

Do you understand the acquisition by the new company Rocket Pharmaceuticals? I think ITEK shareholders get to keep 20% of the new company, and Rocket shareholders get 80% + basically ITEKS cash (and debt position). So....if ITEK at $1.94 has a $52m market cap, it means the new company (when it acquires ITEK via reverse merger) will have a market cap of $260m? Is that correct?

If so, it doesn't seem like a good bet at $1.94. But the biopharma area is beyond my limited skill set.

Meanwhile, I've still got GRVY, so Q3 may be interesting. I wonder why it has jumped from $19 to $33? Hopefully someone paying more attention than me is monitoring GRVY's rankings in the various online stores that sell the GRVY apps.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.